openPR Logo
Press release

Depression Devices Market- Key Vendors ( Fisher Wallace, MagVenture A/S, Electromedical Products International, Inc., Brainsway Ltd, Neuro-Fitness LLC and Boston Scientific Corporation)

04-24-2019 02:44 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

/ PR Agency: Fact.MR
Depression Devices Market- Key Vendors ( Fisher Wallace,

Depression Devices Market – Introduction

Depression is characterized by multiple mental health challenges including lack of positivity, suicidal thoughts, anxiety, insomnia, overeating/loss of appetite, and sadness. Extension of such feelings for a longer duration turns into a serious condition, which results in depression.

Increase in the stressful lifestyles further induces anxiety and sleeplessness, which if left untreated causes severe health threats and even results into suicides. Growing number of depression diagnosed population is generating a pressing need for an effective cure and consumers have been preferring medication to recover from depression. However, numerous studies reporting side-effects of depression drugs have unlocked new avenues for the manufacturers operating in the depression devices market, which is expected to deliver sustained growth to the depression devices market in the upcoming years.

Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=575

Depression Devices Market – Novel Developments

Some of the significant partakers bringing innovation in the depression devices market encompass Fisher Wallace, Boston Scientific Corporation, Neuro-Fitness LLC, Brainsway Ltd, Electromedical Products International, Inc., and MagVenture A/S. Realizing the side-effects caused by the drugs, manufacturers operating in the depression devices market have been capitalizing on the opportunity to offer effective treatment without medication.

Electromedical Products International, Inc. developed an FDA approved depression device, Alpha-Stim®, which boasts a capability to treat depression easily, safely, and quickly. The recommended duration for the use of this device is 20 minutes, however, there is no risk associated with its overuse, which enhances its desirability.
In 2018, MagVenture developed a magnetic stimulation device that claims to treat depressed patients in as little time as 3 minutes. The non-invasive therapy delivers magnetic waves to activate nerve cells, which in turn excites the neurons and alters their mood.
In 2018, a Swedish company – Flow Neuroscience, developed a wearable for depression treatment that involves attaching two electrodes to the sides of the forehead and a weak electrical signal is transmitted to the brain. The company is further set to leverage the online distribution channel for the sales of this device and its availability without the prescription of medical personnel is believed to proliferate its adoption rate.
Depression Devices Market – Dynamics

Ease of Availability in Parallel to the Proliferated Adoption Rate to Contribute to the Growing Depression Devices Market

With the widespread prevalence of depression, governments of numerous countries have been readily granting approvals to the depression devices. This has offered a leeway to manufacturers to develop therapeutic devices and increase their sales prospects with this reduced time-to-market. As a result, portable depression devices that lend convenience to patients are gaining notable traction. Increasing adoption rate of these devices has also been witnessed, on account of the devices being non-invasive.

Another crucial driver delivering growth to the depression devices market is streamlined distribution channel. Traditionally, the stimulation therapies were performed by the medical practitioners and their availability were restricted to only hospitals, homecare settings, rehabilitation centers, and clinics. However, depression devices driven by innovation have resulted in various high-end wearable devices, which can be plugged in and operated without the supervision of doctors.

Ask For Customized Report @ https://www.factmr.com/connectus/sample?flag=RC&rep_id=575

In the future, with the incessant growth of ecommerce portals, sales of depression devices will be easier with their online availability. As a result, regions without any proper depression treatments will, in turn, be able to access these devices, which is anticipated to bode well for the growth of the depression devices market.

North America to Remain an Affluent Market for the Growth of the Depression Devices Market

Geographically, North America is anticipated to contribute the largest share to the depression devices market with a perpetual rise in the stressful lifestyle resulting in a growing number of depressed individuals. In addition, the high concentration of significant partakers working towards developing user-friendly devices is anticipated to maintain its influence on the depression devices market in the forthcoming years. Next in the market, Europe possesses lucrative growth opportunities for the depression devices market with an excellent adoption rate of these devices to offer therapies for treating depression.

Depression Devices Market: Overview

Depression device are very affective for patients suffering from various depression such as, persistent depressive disorder, psychotic depression, postpartum depression, major depression, seasonal affective disorder and others. Various public and private research institutes are working for developing more affective device to recover depression patient and connect them to normal lifestyle. The players are also developing more portable device, so that the depression patient can carry the device for point of care in any time.

Depression Devices Market: Region-wise Outlook

Geographically, Depression devices market is segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, Japan, Middle East and Africa. North America is a major market as the major players are present in the region and the patient pool is also increasing every year. Europe is accepting depression device to provide therapy to recover depression device. Asia Pacific is slowing sluggish growth as the healthcare professional are adapting depression device. In, Middle East and Africa the awareness programs are increasing about the product and the medical use for recover depression patients.

Depression Devices Market: Key Players

Some of the players in depression devices market include: Fisher Wallace, MagVenture A/S, Electromedical Products International, Inc., Brainsway Ltd, Neuro-Fitness LLC and Boston Scientific Corporation.

You can Buy This Report from Here @ https://www.factmr.com/checkout/575/S

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/

Read Industrial News : http://insiderstribune.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Depression Devices Market- Key Vendors ( Fisher Wallace, MagVenture A/S, Electromedical Products International, Inc., Brainsway Ltd, Neuro-Fitness LLC and Boston Scientific Corporation) here

News-ID: 1716259 • Views:

More Releases from Fact.MR

Bagless Vacuum Cleaners Market Is Predicted To Touch US$ 39.52 Billion By 2033: Fact.MR Report
Bagless Vacuum Cleaners Market Is Predicted To Touch US$ 39.52 Billion By 2033: …
The global demand for bagless vacuum cleaners is forecasted to experience a compound annual growth rate (CAGR) of 8% from 2023 to 2033. Consequently, the market for bagless vacuum cleaners worldwide is anticipated to surge from a value of US$ 18.3 billion in 2023 to reach US$ 39.52 billion by the end of 2033. The Bagless Vacuum Cleaner Industry sales study offers a comprehensive analysis on diverse features including production
NFC Chips Are Predicted To Reach US$ 7.6 Billion At A CAGR Of 15% By 2033: Fact.MR Report
NFC Chips Are Predicted To Reach US$ 7.6 Billion At A CAGR Of 15% By 2033: Fact. …
The global NFC chip market is valued at US$ 1.9 billion in 2023 and is forecasted to surge at a CAGR of 15% to reach a market size of US$ 7.6 billion by the end of 2033. The NFC Chip Industry sales study offers a comprehensive analysis on diverse features including production capacities, NFC Chip demand, product developments, sales revenue generation and NFC Chip market outlook across the globe. market research
Canned Beans Market Is Anticipated To Reach US$ 15 Billion By 2033: Fact.MR Report
Canned Beans Market Is Anticipated To Reach US$ 15 Billion By 2033: Fact.MR Repo …
The global canned beans market is valued at US$ 5.65 billion in 2023 and is projected to reach US$ 15 billion by the end of 2033, expanding at a high-value CAGR of 10.3% from 2023 to 2033. The Canned Beans Industry sales study offers a comprehensive analysis on diverse features including production capacities, Canned Beans demand, product developments, sales revenue generation and Canned Beans market outlook across the globe. market research
Plasma Fractionation Market Projected to Reach US$ 65 Billion by 2032, With 7.3% CAGR | Fact.MR
04-25-2024 | Health & Medicine
Fact.MR
Plasma Fractionation Market Projected to Reach US$ 65 Billion by 2032, With 7.3% …
The plasma fractionation market is projected to be valued US$ 32 billion in 2022. Moreover, growth is anticipated to pick up speed at a 7.3% CAGR over the assessment period of 2022-2032 and reach US$ 65 billion. The primary driver of the market's growth is the aging of the global population, which makes people more vulnerable to rare illnesses that call for the usage of blood derivatives. Furthermore, it is anticipated

All 5 Releases


More Releases for Depression

Increase in the prevalence of anxiety disorders and depression is bolstering the …
The research report "Global Anxiety Disorders and Depression Treatment Market: By Product Type (MAOIs (Monoamine Oxidase inhibitors), Atypical Antipsychotics, Benzodiazepines, Anticonvulsants, Beta-Blockers, SRIs (Selective Serotonin Reuptake Inhibitors), SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors), TeCAs (Tetracyclic Antidepressants), TCAs (Tricyclic Antidepressants), Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Others), and Geography- Global/Region/Country Forecast to 2028." The global anxiety disorders and depression treatment market size was valued at USD 8.2 Bn in the year
Depression Treatment Device Market: Information by Product Type (Light Therapies …
Depression is characterized by multiple mental health challenges that involve a lack of positivity, suicidal thoughts, insomnia, anxiety, loss of appetite, and sadness. Depression is caused by a combination of biological, genetic, environmental, and psychological factors. Globally, the prevalence of depression is increasing at an alarming rate. About 300 million people of all ages suffered from depression and the suicide rate rose to about 8,00,000 individuals in 2018. As per
Depression Cannot Hit A Moving Target
Cottonwood Heights, Utah, Mar 12, 2020 -- Depression can't hit a moving target. That was a phrase to live by for Chelsea Hansen. She was full of life and love, and she had big goals. But soon she was to discover that life doesn't turn out the way she planned. Behind the Fake Smile is a fictional book based on real-life experiences. It's the story of how Chelsea navigates a world
Depression Drugs Market: Increase in Cases of Depression to Boost Market Growth
Transparency Market Research (TMR) has published a new report titled, “Depression Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global depression drugs market was valued at US$ 6,500 Mn in 2017 and is anticipated to decline at a CAGR of 2% from 2018 to 2026. The report suggests that rise in incidence of major depression disorders is projected to drive
Depression Therapeutics Market Forecast till 2025
Antidepressants are used to treat a wide range of mental disorders, including depression, anxiety, and major depressive disorder. Certain neurotransmitters in the brain exist in chemical form such as dopamine and serotonin, which are responsible for maintaining emotional balance such as mood and behavior. Antidepressants cover a wide range of drug categories, including selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants
Depression Drug Market: Global Depression Drug Forecast Will Reach $16.8 billion …
Zion Market Research has published a new report titled “Depression Drug (Benzodiazepines, SNRIs, TCAs, TeCAs, Atypical Antipsychotics, Monoamine Oxidase inhibitors and Others) Market: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 – 2020” According to the report, the global depression drug market was valued at USD 14.51 billion in 2014 and is expected to generate revenue of USD 16.8 billion by end of 2020, growing at a CAGR of 2.50%